Compatibility of topical agents with tumor treating fields (TTFields) for treatment of associated skin events in glioblastoma (GBM).

被引：0
|
作者：
Giladi, Moshe
Lacouture, Mario E.
Weinberg, Uri
Bomzon, Zeev
Palti, Yoram
机构：
[1] Novocure Ltd, Haifa, Israel
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e24126
引用
收藏
页数：1
相关论文
共 50 条
  • [1] MODELING THE SAFETY OF TOPICAL AGENTS FOR SKIN TOXICITY ASSOCIATED WITH TUMOR TREATING FIELDS THERAPY IN GLIOBLASTOMA
    Lacouture, M.
    Hershkovich, H.
    Giladi, M.
    Blat, R.
    Bomzon, Z.
    Kirson, E.
    Weinberg, U.
    Palti, Y.
    NEURO-ONCOLOGY, 2018, 20 : 293 - 293
  • [2] MODELING THE SAFETY OF TOPICAL AGENTS FOR SKIN TOXICITY ASSOCIATED WITH TUMOR TREATING FIELDS THERAPY IN GLIOBLASTOMA
    Lacouture, Mario
    Hershkovich, Hadas
    Giladi, Moshe
    Bomzon, Zeev
    Kirson, Eilon
    Weinberg, Uri
    Plati, Yoram
    NEURO-ONCOLOGY, 2018, 20 : 85 - 85
  • [3] Chemoradiation Treatment with or without Concurrent Tumor-Treating Fields (TTFields) in Patients with Newly Diagnosed Glioblastoma (GBM)
    Cappelli, L.
    Kanyne, A.
    Pan, P. C.
    Cordova, J. S.
    Huang, J.
    Wang, T. J. C.
    Alnahhas, I.
    Shi, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E68 - E68
  • [4] HISTOPATHOLOGICAL AND GENOMIC CHARACTERIZATION OF GLIOBLASTOMA (GBM) RESECTED AFTER TUMOR TREATING FIELDS (TTFIELDS) THERAPY
    Michelhaugh, Sharon
    Kiousis, Sam
    Mittal, Sandeep
    NEURO-ONCOLOGY, 2018, 20 : 223 - 223
  • [5] ENHANCED THERAPEUTIC BENEFITS OF TUMOR TREATING FIELDS (TTFIELDs) ON SUPERFICIALLY LOCATED GLIOBLASTOMA MULTIFORME (GBM)
    Harris, David
    Kumar, Vaibhav
    Mehan, William
    Madan, Neel
    Moreno-Koehler, Alejandro
    Linendoll, Nadine
    Saif, Nawal
    Quinkert, Amy
    Mignano, John
    Wu, Julian
    Jeyapalan, Suriya
    NEURO-ONCOLOGY, 2016, 18 : 180 - 180
  • [6] Modeling Intersubject Differences in Tumor Treating Fields (TTFields) Treatment of GBM Patients
    Wenger, C.
    Salvador, R.
    Basser, P.
    Miranda, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E71 - E71
  • [7] CHEMORADIATION (CRT) TREATMENT WITH OR WITHOUT CONCURRENT TUMOR-TREATING FIELDS (TTFIELDS) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Cappelli, Louis
    Kayne, Allison
    Pan, Peter
    Cordova, James
    Huang, Jiayi
    Wang, Tony
    Alnahhas, Iyad
    Shi, Wenyin
    NEURO-ONCOLOGY, 2022, 24 : 53 - 53
  • [8] Chemoradiation treatment with or without concurrent tumor-treating fields (TTFields) therapy in newly diagnosed glioblastoma (GBM) patients in China
    Liping Liang
    Lingchao Chen
    Chunxia Ni
    Wenyin Shi
    Zhirui Zhou
    Shu Chen
    Wenjia Zhu
    Jiabing Liu
    Xianxin Qiu
    Wanzun Lin
    Junyan Zhang
    Zhiyong Qin
    Yang Wang
    Chinese Neurosurgical Journal, 11 (1)
  • [9] CLINICAL EXPERIENCES OF TUMOR TREATING FIELDS (TTFIELDS) IN PEDIATRIC PATIENTS WITH GBM
    Crawford, John
    Dhall, Girish
    Margol, Ashley
    Saria, Marlon
    Kesari, Santosh
    NEURO-ONCOLOGY, 2016, 18 : 139 - 139
  • [10] TUMOR TREATING FIELDS (TTFIELDS) THERAPY IN GLIOBLASTOMA (GBM): RELATIONSHIP BETWEEN PATIENT EXPERIENCE, GLOBAL REGION, AND AGE
    Shockley, Shermona
    Gwyn, P. Gage
    Adams, Renae
    Batzianouli, Eleni
    Johnson, Heather
    Abdullah, Huda Ismail
    NEURO-ONCOLOGY, 2023, 25
12345